y16M Antibody

What is the Y164 antibody and what cellular targets does it recognize?

The Y164 antibody is a rabbit recombinant monoclonal antibody that specifically recognizes BAK (Bcl-2 homologous antagonist/killer, also known as BCL2L7 or CDN1). BAK plays a critical role in the mitochondrial apoptotic process. Upon receiving cell death signals, BAK promotes mitochondrial outer membrane (MOM) permeabilization by forming oligomeric pores within the MOM. This permeabilization releases apoptogenic factors into the cytosol, including cytochrome c, which activates caspase 9 and subsequently triggers the effector caspases .

The antibody has been validated for various applications including immunoprecipitation (IP), western blotting (WB), flow cytometry (intracellular), and immunohistochemistry on paraffin-embedded samples (IHC-P) .

How does Y164 differ from other BAK-targeting antibodies in terms of specificity?

The Y164 antibody has been knockout tested, meaning its specificity has been verified using BAK knockout samples, which provides a significant advantage over non-validated antibodies. This validation ensures that the antibody specifically recognizes the intended target protein with minimal cross-reactivity .

Unlike many conventional antibodies, the Y164 is available in a BSA and azide-free format, making it suitable for conjugation with fluorochromes, metal isotopes, oligonucleotides, and enzymes. This versatility makes the antibody ideal for antibody labeling, functional assays, cell-based assays, flow cytometry applications (including mass cytometry), and multiplex imaging applications .

What protocols are recommended for immunoprecipitation using Y164 antibody?

For immunoprecipitation using the Y164 antibody, the following protocol has been validated:

• Dilute the purified form of Y164 antibody to a concentration of 1:20 (equivalent to 2μg) in an appropriate buffer.

• Add the diluted antibody to whole cell lysate (e.g., HeLa cell lysate).

• Follow standard immunoprecipitation procedures, including appropriate washing steps.

• Analyze the precipitated proteins via SDS-PAGE and subsequent Western blotting .

A successful example shows the antibody effectively immunoprecipitating BAK from human cervix adenocarcinoma epithelial cell (HeLa) whole cell lysate. For optimal results, include both an input control (10μg of whole cell lysate) and a positive control (Y164 antibody with HeLa lysate) .

How should researchers optimize antibody concentrations for different applications?

The optimal antibody concentration varies significantly depending on the application:

Researchers should always perform a titration experiment to determine the optimal concentration for their specific experimental conditions. Starting with the manufacturer's recommended dilution and then testing 2-3 dilutions on either side is a systematic approach to optimization .

How can Y164 antibody be utilized in apoptosis research?

The Y164 antibody is particularly valuable in apoptosis research due to BAK's central role in the mitochondrial apoptotic pathway. Researchers can employ this antibody to:

• Track BAK activation and oligomerization: During apoptosis, BAK undergoes conformational changes and forms oligomers. The Y164 antibody can detect these changes through approaches such as immunofluorescence microscopy or flow cytometry.

• Study mitochondrial permeabilization: Combined with mitochondrial markers, the Y164 antibody can help identify the timing and extent of mitochondrial outer membrane permeabilization in various cell death scenarios.

• Investigate protein-protein interactions: Using the Y164 antibody in co-immunoprecipitation experiments allows researchers to study BAK's interactions with other pro- and anti-apoptotic Bcl-2 family members under different cellular conditions.

• Analyze BAK expression levels: The antibody can quantify BAK expression across different cell types or following various treatments, providing insights into cellular sensitivity to apoptotic stimuli .

What approaches can resolve inconsistent results with Y164 antibody?

When encountering inconsistent results with the Y164 antibody, researchers should systematically troubleshoot through the following approaches:

• Verify antibody functionality: Test the antibody on a positive control sample known to express BAK (such as HeLa cells).

• Optimize fixation and permeabilization conditions: BAK is a mitochondrial membrane protein, so proper membrane permeabilization is crucial for antibody access.

• Check for post-translational modifications: Under certain conditions, BAK may undergo modifications that affect epitope recognition. Consider using alternative antibodies targeting different epitopes.

• Evaluate protein extraction methods: For membrane-associated proteins like BAK, extraction conditions significantly impact antibody detection. Different detergents and buffer compositions should be tested.

• Cross-validate with orthogonal methods: Complement antibody-based detection with mRNA analysis or tagged protein expression to confirm observations .

How should researchers analyze flow cytometry data generated with Y164 antibody?

Analysis of flow cytometry data using the Y164 antibody should follow these methodological steps:

• Establish proper gating strategies: Begin with forward/side scatter gating to identify intact cells, followed by singlet selection and exclusion of dead cells.

• Include appropriate controls: An isotype control antibody helps establish background staining levels. Additionally, include a positive control sample (known to express BAK) and, ideally, a negative control (BAK knockout cells if available).

• Quantitative analysis approaches:

  • For population shifts: Report the median fluorescence intensity (MFI) and percent positive cells above the isotype threshold.

  • For conformational changes: Consider using specialized staining protocols that specifically detect activated BAK.

• Statistical analysis: When comparing BAK expression across conditions, utilize appropriate statistical tests based on your experimental design. For normally distributed data, t-tests or ANOVA may be appropriate. For non-parametric data, consider tests like Mann-Whitney or Kruskal-Wallis .

• Data visualization: Present flow cytometry data as histogram overlays or dot plots with clear indication of gating boundaries. For quantitative comparisons, bar graphs showing MFI with error bars are recommended .

What statistical approaches are appropriate for antibody binding data interpretation?

Antibody binding data often follows complex distributions that may not be normally distributed. Based on the search results, several statistical approaches are particularly suited for antibody data analysis:

• Finite mixture models: These models can help identify distinct serological populations (e.g., seronegative vs. seropositive) within a dataset. They're particularly useful when antibody concentrations follow skewed distributions.

• Skew-Normal and Skew-t distributions: These distributions provide more flexibility than standard normal distributions and are often more appropriate for modeling antibody data that shows asymmetry. For example, antibody levels often show negative skewness in seropositive populations, as antibodies decay over time in the absence of repeated infections .

• Likelihood ratio tests: These can be used to determine if a single distribution or a mixture of distributions better describes your antibody binding data.

• Bootstrap methods: For small sample sizes, bootstrap methods provide more robust confidence intervals than standard parametric approaches .

A key insight from empirical studies is that antibody distributions often exhibit negative skewness in seropositive populations, with estimates of skewness ranging from -1.87 to -5.14 for different antibodies. This statistical characteristic should be considered when analyzing Y164 antibody binding data .

How can Y164 antibody be modified for advanced imaging applications?

The carrier-free format of Y164 antibody makes it particularly suitable for conjugation with various reporter molecules for advanced imaging applications:

• Fluorochrome conjugation: The antibody can be directly labeled with fluorescent dyes for confocal microscopy, super-resolution microscopy, or flow cytometry applications. This eliminates the need for secondary antibodies, reducing background and improving signal specificity.

• Metal isotope labeling: For mass cytometry (CyTOF) applications, Y164 can be conjugated with rare earth metal isotopes, enabling highly multiplexed analysis of BAK alongside numerous other cellular markers simultaneously.

• Nanoparticle probing: The antibody can be conjugated to nanoparticles such as colloidal gold or silver, which provides several advantages:

  • Improved assay sensitivity and specificity

  • Lower limit of detection (LOD)

  • Expanded dose response range (up to 10,000-fold compared to standard methods)

  • Enhanced detection sensitivity (up to 1,000-fold compared to ELISA)

• Quantum dot labeling: Conjugation with quantum dots allows for multicolor imaging with exceptional photostability, enabling long-term tracking of BAK localization and dynamics .

What are the emerging techniques for customizing antibody specificity profiles like Y164?

Recent advances in antibody engineering allow researchers to customize specificity profiles of antibodies like Y164:

• Computational modeling approaches: Biophysics-informed modeling techniques can now predict antibody-antigen interactions and guide the design of antibodies with desired specificity profiles. These models identify different binding modes associated with particular targets and can be used to engineer antibodies with either:

  • Highly specific binding to a singular target

  • Cross-specificity for multiple defined targets

• Phage display optimization: Advanced phage display experiments with antibody libraries can be combined with high-throughput sequencing to systematically vary complementary determining regions (CDRs). For example, systematic variation of four consecutive positions in CDR3 can create libraries with up to 160,000 combinations, allowing selection of antibodies with optimal binding properties .

• Energy function optimization: Novel computational approaches optimize energy functions associated with binding modes to engineer antibodies with customized specificity:

  • For cross-specific binding: Jointly minimizing energy functions associated with desired targets

  • For highly specific binding: Minimizing energy for the desired target while maximizing energy for undesired targets

These emerging techniques could be applied to modify Y164 or generate new antibodies with customized BAK-binding properties for specialized research applications.

What are effective validation strategies to confirm Y164 antibody specificity?

To rigorously validate Y164 antibody specificity, researchers should implement multiple complementary approaches:

• Knockout validation: The gold standard for antibody validation is testing on samples where the target protein (BAK) has been genetically knocked out. The antibody should show no signal in these samples .

• Knockdown controls: If knockout samples aren't available, siRNA or shRNA-mediated knockdown of BAK should produce a corresponding reduction in signal intensity.

• Multiple detection methods: Confirm observations using at least two different detection methods (e.g., Western blot and immunofluorescence).

• Epitope blocking: Pre-incubation of the antibody with the immunizing peptide should abolish specific staining.

• Cross-validation with other antibodies: Compare results with other well-characterized antibodies targeting different epitopes of BAK.

• Molecular weight verification: In Western blot applications, verify that the detected band corresponds to the expected molecular weight of BAK (approximately 23-25 kDa) .

What troubleshooting approaches are recommended when Y164 antibody produces unexpected results?

When unexpected results occur with Y164 antibody, systematic troubleshooting should include:

• Antibody integrity assessment: Verify proper storage conditions were maintained. Consider running a small amount on a gel to check for antibody degradation.

• Sample preparation evaluation: For mitochondrial proteins like BAK, ensure:

  • Complete cell lysis

  • Proper membrane solubilization

  • Prevention of protein degradation using appropriate protease inhibitors

  • Avoidance of excessive heating which may cause protein aggregation

• Protocol optimization matrix: Create a systematic grid testing multiple variables:

• Signal amplification: For weak signals, consider using signal amplification methods like tyramide signal amplification or polymer-based detection systems.

• Technical replicates: Perform at least three independent experiments to distinguish technical issues from biological variability .